Remove Manufacturing Remove Physicians Remove Safety Remove Side effects
article thumbnail

What GLP-1 drugs mean for medtech

Clarivate

GLP-1s will offer an attractive option to patients hesitant to undergo an invasive surgical procedure, and manufacturers like Medtronic and Johnson & Johnson anticipate a temporary dip in surgery volumes. Device-based treatments for comorbidities associated with obesity will also see an impact.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Communication and follow-up with the physician. Patient education and medication adverse effect counselling. Patient monitoring for safety and efficacy. Payer and/or manufacturer reporting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. CareTrack Health.

article thumbnail

How to Boost Pharma Sales AI Training with AI Insights

Quantified

They also need to know which conditions each medication treats and accurately convey their therapeutic benefits, safety profiles, possible side effects, and the most recent data available related to patient outcomes. Most find it increasingly difficult to arrange one-on-one meetings with prescribing physicians.

article thumbnail

12 New Ways Companies Are Helping to Improve Adherence

PM360

1 Healthline Media’s new solution, Rx Savings Program, is an interactive experience on its drug information pages that drives users to take action with manufacturer drug savings programs, helping them better afford and adhere to treatment. Nearly three in five people have experienced out-of-pocket prescription costs they couldn’t afford.

article thumbnail

The Future of Biosimilars Marketing

PM360

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. As we found in our latest physician survey, physicians are actively seeking more information on key topics such as patient affordability, patient eligibility, clinical results, formulary coverage, and more.

article thumbnail

Two Key Questions About Patient Experience in 2022

PM360

Life sciences are being driven to improve the patient experience and are increasingly accomplishing this through innovative programs and resources for patients and physicians that improve access to medications, help make prescriptions more affordable, and support patients with adherence.